文献速递膀胱癌与上尿路尿路上皮癌

磁共振成像对膀胱癌肿瘤分期的诊断准确性:系统评价与荟萃分析

Diagnostic accuracy of magnetic resonance imaging for tumour staging of bladder cancer: systematic review and meta-analysis.
PubMed 文献 · BJU Int · 2018-06-03

该系统评价纳入30项研究共5156例膀胱癌患者,采用双变量随机效应荟萃分析评估MRI对四个T分期阈值的诊断准确性。结果显示≤T1 vs ≥T2的敏感度87%、特异度79%,≤T2 vs ≥T3的敏感度83%、特异度87%,<T4b vs pT4b的敏感度85%、特异度98%,而T-any vs T0的敏感度仅65%。作者认为MRI在部分分期阈值上可能优于现有临床分期标准,但需谨慎解读并开展验证试验。

要点

  • MRI对≤T1 vs ≥T2的敏感度87%、特异度79%,低偏倚风险研究中准确性更高。
  • MRI对≤T2 vs ≥T3的敏感度83%、特异度87%,特异度明显高于临床分期。
  • MRI对T-any vs T0的敏感度仅65%,准确性可能不优于临床分期。

核心结论

  • MRI对≤T1 vs ≥T2、≤T2 vs ≥T3和<T4b vs pT4b的分期准确性可能优于当前临床分期标准。
  • MRI对T-any vs T0的准确性可能不优于临床分期。
  • 由于偏倚风险和样本量限制,需谨慎解读并开展比较临床分期策略与MRI的验证试验。

研究设计与样本

  • 系统评价与荟萃分析,纳入30项研究共5156例接受T分期MRI的膀胱癌患者。
  • 采用双变量随机效应模型汇总诊断准确性,亚组分析探索异质性来源,QUADAS-2评估偏倚风险。

主要发现

  • ≤T1 vs ≥T2:敏感度87%(95%CI 82-91),特异度79%(95%CI 72-85)。
  • T-any vs T0:敏感度65%(95%CI 23-92),特异度90%(95%CI 83-94)。
  • ≤T2 vs ≥T3:敏感度83%(95%CI 75-88),特异度87%(95%CI 78-93)。
  • <T4b vs pT4b:敏感度85%(95%CI 63-95),特异度98%(95%CI 95-99)。
  • ≤T1 vs ≥T2的准确性在低偏倚风险研究中更高;场强、经尿道膀胱肿瘤电切状态、发表时间、索引测试参数未显示与准确性变异相关。

关键数值与推荐

  • ≤T1 vs ≥T2准确性高于临床分期报告值。
  • T-any vs T0准确性低于临床分期。
  • ≤T2 vs ≥T3敏感度略低于临床分期但特异度显著更高。
  • <T4b vs pT4b敏感度超过临床分期的估计准确性。

临床怎么用

  • 对于≤T1 vs ≥T2、≤T2 vs ≥T3和<T4b vs pT4b的分期需求,可考虑将MRI作为潜在优于临床分期的评估手段。
  • 对于T-any vs T0的鉴别,MRI准确性可能不优于临床分期,应结合其他信息谨慎判断。
  • 临床应用中需注意研究偏倚风险和样本量限制,并等待比较临床分期策略与MRI的验证试验结果。

局限性

  • T-any vs T0和<T4b vs pT4b两个场景纳入研究数量少。
  • 多项研究存在高偏倚风险。
  • 需开展比较临床分期策略与MRI的试验进行验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The purpose of this study is to evaluate accuracy of magnetic resonance imaging (MRI) for local staging of bladder cancer for four clinical scenarios (T-stage thresholds) considered against current standards for clinical staging and secondarily to identify sources for variability in accuracy. Systematic review of patients with bladder cancer undergoing T-staging MRI to evaluate the diagnostic accuracy using bivariate random-effects meta-analysis. Sub-group analysis was done to explore variability; risk of bias was assessed using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS)-2 tool. The search identified 30 studies (5156 patients). Pooled accuracy at multiple T-stage thresholds: ≤T1 vs ≥T2 = sensitivity 87% (95% confidence interval [CI] 82-91), specificity 79% (95% CI 72-85); T-any vs T0 = sensitivity 65% (95% CI 23-92), specificity 90% (95% CI 83-94); ≤T2 vs ≥T3 = sensitivity 83% (95% CI 75-88), specificity 87% (95% CI 78-93); and <T4b vs pT4b = sensitivity 85% (95% CI 63-95), specificity 98% (95% CI 95-99). For ≤T1 vs ≥T2, accuracy was higher in studies at low risk of bias. No variability in accuracy was identified for: field strength, transurethral resection of bladder tumour status, publication date, index test parameters. For ≤T1 vs ≥T2, accuracy was higher than reported for clinical staging. For T-any vs T0 accuracy was lower than clinical staging. For ≤T2 vs ≥T3, sensitivity was slightly lower than clinical staging but specificity was considerably higher. For <T4b vs pT4b sensitivity exceeded the estimated accuracy for clinical staging. Limitations: two scenarios had few studies (T-any vs T0; <T4b vs pT4b) and several studies were at high risk of bias. MRI staging for ≤T1 vs ≥T2, ≤T2 vs ≥T3, and <T4b vs pT4b should be considered as potentially superior to the current standard for clinical staging. MRI accuracy for T-any vs T0 may not be superior to clinical staging. However, cautious interpretation is warranted related to risk of bias and sample size; validation in trials comparing clinical staging strategies vs MRI is warranted.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Gandhi N, Krishna S, Booth CM, et al. Diagnostic accuracy of magnetic resonance imaging for tumour staging of bladder cancer: systematic review and meta-analysis. BJU Int. 2018. PMID: 29727910. doi:10.1111/bju.14366

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。